Chalmers l (2002) Lessons for research ethics committees. Lancet 359: 174–174PubMedCrossRef

Chimonas S, Brennan T, Rothman D (2007) Physicians and drug representatives: exploring the dynamics of the relationship. J Gen Intern Med 22: 184–190PubMedCrossRef

Choudhry NK, Stelfox HT, Detsky AS (2002) Relationships between authors of clinical practice guidelines and the pharmaceutical industry. JAMA 287 (5): 612–617

Clade H (2001) Drittmittelfinanzierung: Strenge Regeln für das Sponsoring. Dtsch Ärztebl 98 (40): C2043–C2044

Collier J, Iheanacho I (2002) The pharmaceutical industry as an informant. Lancet 360: 1405–1409PubMedCrossRef

Connell CM, Shaw B, Holmes SB, Forster NL (2001) Caregivers’ attitudes toward their family members’ participation in Alzheimer disease research: implications for recruitment and retention. Alzheimer Dis Assoc Disord 15: 137–145PubMedCrossRef

Cowley AJ, Skene A, Stainer K, Hampton JR (1993) The effect of lorcainide on arrhythmias and survival in patients with acute myocardial infarction: an example of publication bias. Int J Cardiol 40 (2): 161–162

Coyle SL (2002) Physician–industry relations. Part 1: Individual physicians. Ann Intern Med 136: 396–402PubMedCrossRef

Davidoff F, De Angelis CD, Drazen JM, Nicholls MG, Hoey J, Hojgaard L, Horton R, Kotzin S, Nylenna M, Overbeke AJ, Van Der Weyden MB, Wilkes MS (2001) Sponsorhip, autorship and accountability. Ann Intern Med 135: 463–466PubMedCrossRef

De Angelis C, Fontanarosa PB (2010) Strengthening the credibility of clinical research. Lancet 376: 234CrossRef

De Angelis CD (2000) Conflict of interest and the public trust. JAMA 284 (17): 2237

De Angelis CD, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, Kotzin S, Laine C, Marusic A, Overbeke AJ, Schroeder TV, Sox HC, Van Der Weyden MB (2005) Is this clinical trial fully registered? Statement from the International Committee of Medical Journal Editors. Lancet 365: 1827–1829

DFG (1998/2011) Sicherung guter wissenschaftlicher Praxis. http://wwwdfgde/en/research_funding/legal_conditions/good_scientific_practice/indexhtml. Zugegriffen: 05.01.12

Dhanda RK (2002) Guiding Ikarus – Merging bioethics with corporate interests? Wiley, New York

Dieperink ME, Drogemuller L (2001) Effects of industry sponsorship of grand rounds. JAMA 286 (8): 918

Dittmann RW, Linden M, Osterheider M, Schaaf B, Ohnmacht U, Weber HJ (1997) Antidepressant drug use: differences between psychiatrists and general practitioners. Results from a drug utilization observation study with Fluoxetin. Pharmacopsychiat 30 (suppl): 28–34

Drazen JM, Curfman GD (2002) Financial associations of authors. N Engl J Med 346 (24): 1901–1902

E.T.H. Zürich (2011) Richtlinien für Integrität in der Forschung und gute wissenschaftliche Praxis an der ETH Zürich. http://www.rechtssammlung.ethz.ch/pdf/414_Integrit%C3%A4t_Forschung.pdf. Zugegriffen: 02.02.13

Editorial (2001) Look, no strings: publishing industry-funded research. CMAJ 165 (6): 733–733

Editorial (2012) Promoting research integrity: a new global effort. Lancet 380: 1445

Editorial (2002) The controlling interests of research. CMAJ 167 (11): 1221–1221

Editors of Medical Journals (2011) Committee on publication ethics (COPE). http://publicationethics.org/about. Zugegriffen: 04.02.13

European Science Foundation (2003) Press release on registration of randomised controlled trials. http://www.esf.org/esf_pressarea_page.ph…nt=1&language=o&section=66&newsrelease=60. Zugegriffen: 04.02.13

Fava GA (2010) Conflicts of interest. In: Helmchen H, Sartorius N (Hrsg) Ethics in Psychiatry. Springer, Dordrecht, S 55–73CrossRef